PPHF-2015-Enhanced Surveillance for New Vaccine Preventable Disease - A Program Expansion for Acute
The main purpose of this supplemental funding announcement is to support a network of US institutions to assess influenza VE in preventing laboratory-confirmed influenza infections among hospitalized children aged <18 years. A second purpose of the supplement is to establish an inpatient surveillance network for surveillance of important non-influenza viral pathogens associated with pediatric acute respiratory illness, including RSV and EV-D68, among children aged <5 years.
General information about this opportunity
Last Known Status
Deleted 06/25/2015 (Archived.)
Program Number
RFA-IP-11-0100501PPHF15 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: CENTERS FOR DISEASE CONTROL
Type(s) of Assistance Offered
Cooperative Agreement Number of Awards Available
7 Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
The following organizations are eligible to apply: Vanderbilt University School of Medicine, Nashville, TN University of Rochester School of Medicine and Dentistry, Rochester, NY Cincinnati Children's Hospital Medical Center, Cincinnati, OH Texas Children's Hospital, Houston, TX Seattle Children's Hospital, Seattle, WA Children's Mercy Hospital and Clinics, Kansas City, MO Children's Hospital and Research Center, Oakland, CA What is the process for applying and being award this assistance?
Deadlines
05/26/2015 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
Technical Information Management Section (TIMS) 2960 Brandywine Road
Atlanta, GA 30341
Office phone: 770-488-2700
Fax: 770-488-8350
E-mail Address
PGOTIM@cdc.gov
Financial Information
Obligations
$3,500,000.00
